ANEBULO PHARMACEUTICALS, INC. Payments for Repurchase of Initial Public Offering
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Payments for Repurchase of Initial Public Offering of $248.93 thousand for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2023-05-11
- ANEBULO PHARMACEUTICALS, INC. payments for repurchase of initial public offering for the quarter ending 2023-03-31 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. payments for repurchase of initial public offering for the quarter ending 2022-12-31 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. payments for repurchase of initial public offering for the quarter ending 2022-09-30 was $248.93K.
- ANEBULO PHARMACEUTICALS, INC. payments for repurchase of initial public offering for fiscal 2021 was $821.63K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $248.93K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $248.93K 10-Q · filed 2023-02-10 | ||
| 2022-09-30 | $248.93K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $821.63K 10-K · filed 2022-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |